Market Insights Health Pharmacies OTC Products

Hand Sanitizer (Pharmacies) - Asia

Asia

Revenue in the Hand Sanitizer market is projected to reach €0.81bn in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 3.24%, resulting in a market volume of €0.95bn by 2029.
In global comparison, most revenue will be generated in China (€353.50m in 2024).
In relation to total population figures, per person revenues of €0.18 are generated in 2024.

Key regions: Japan, United States, Europe, United Kingdom, Canada

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Hand Sanitizer (Pharmacies) market in Asia has been experiencing significant growth in recent years. Customer preferences for hand sanitizers have evolved due to various factors, leading to an increase in demand for these products. Additionally, local special circumstances and underlying macroeconomic factors have also contributed to the development of the market.

Customer preferences: Customers in Asia have become more conscious of personal hygiene and the importance of hand sanitization. This shift in mindset has been driven by increasing awareness about the spread of diseases and the need to maintain cleanliness. As a result, there has been a growing demand for hand sanitizers in pharmacies across the region. Customers are seeking products that are effective in killing germs and bacteria, while also being gentle on the skin. They are also looking for hand sanitizers that are convenient to use and have a pleasant fragrance.

Trends in the market: One of the key trends in the Hand Sanitizer (Pharmacies) market in Asia is the rising popularity of natural and organic hand sanitizers. Customers are becoming more health-conscious and are seeking products that are free from harsh chemicals and artificial fragrances. This trend is driven by a growing preference for eco-friendly and sustainable products. As a result, pharmacies are stocking a wider range of natural and organic hand sanitizers to cater to this demand. Another trend in the market is the increasing availability of hand sanitizers with moisturizing properties. Many customers in Asia have reported that regular use of hand sanitizers can cause dryness and irritation. In response to this feedback, manufacturers have started incorporating moisturizing ingredients in their hand sanitizers. This has been well-received by customers, who are now more inclined to purchase hand sanitizers that provide hydration and nourishment to their skin.

Local special circumstances: Certain countries in Asia have faced public health emergencies in recent years, such as outbreaks of infectious diseases. These incidents have led to a heightened awareness of the importance of hand sanitization and hygiene practices. As a result, the demand for hand sanitizers in these countries has surged significantly. Pharmacies have played a crucial role in meeting this increased demand by stocking a wide range of hand sanitizers and ensuring their availability to the public.

Underlying macroeconomic factors: The Hand Sanitizer (Pharmacies) market in Asia has also been influenced by underlying macroeconomic factors. Economic growth in the region has resulted in an increase in disposable income levels, allowing customers to spend more on personal care products. Additionally, urbanization and changing lifestyles have led to a higher demand for convenience products, including hand sanitizers. These factors have contributed to the overall growth of the market in Asia. In conclusion, the Hand Sanitizer (Pharmacies) market in Asia is experiencing significant growth due to evolving customer preferences, including a preference for natural and organic products as well as hand sanitizers with moisturizing properties. Local special circumstances, such as public health emergencies, have also contributed to the development of the market. Furthermore, underlying macroeconomic factors, including economic growth and changing lifestyles, have played a role in driving the demand for hand sanitizers in pharmacies across the region.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.